化痰祛瘀方联合肝动脉化疗栓塞术治疗中晚期原发性肝癌
2016-01-09文庆贤,郭萍,蒋树龙
化痰祛瘀方联合肝动脉化疗栓塞术治疗中晚期原发性肝癌
文庆贤,郭萍,蒋树龙*
(济宁市第一人民医院,山东 济宁 272000)
摘要:目的观察化痰祛瘀方联合肝动脉化疗栓塞术(TACE)治疗中晚期原发性肝癌的临床疗效。方法68例中晚期肝癌患者根据数字表法随机分为2组,对照组33例(TACE治疗),治疗组35例(化痰祛瘀方+TACE治疗),治疗3个月后,观察2组肝功能、KPS评分、肿瘤标志物、瘤体大小、中医证候评分等的变化情况。结果治疗组与对照组近期总有效率分别是65.71%和42.42%,差异有统计学意义(P<0.05);治疗28 d后,治疗组肝功能指标谷丙转氨酶(ALT)、谷草转氨酶(AST)、谷氨酰转肽酶(GGT)下降水平明显优于对照组(P<0.05);治疗3个月后,治疗组在改善患者的生活质量(KPS评分)及中医证侯(乏力、胁痛、腹胀、便溏、纳差)方面具有优势(P<0.05)。结论化痰祛瘀方联合TACE治疗中晚期肝癌能有效改善肝功能、生活质量及中医证候指标。
关键词:中晚期肝癌;肝动脉化疗栓塞术;化痰祛瘀;丹参;姜半夏
DOI:10.13463/j.cnki.jlzyy.2015.02.015
中图分类号:R735.7文献标志码: A
文章编号:1003-5699(2015)02-0150-04
基金项目:国家自然科学基金资助项目(81403346),中国博士后科学
作者简介:文庆贤(1972-),女,大学本科,主管护师,主要从事慢性病的康复治疗。
收稿日期:(责任编辑:王丹2014-10-30)

*通信作者:蒋树龙,电子信箱-jnsljiang@163.com。
HuaTanQuYu prescription combined with TACE treatment for advanced primary liver cancer
WEN Qingxian,GUO Ping,JIANG Shulong*
(Jining First People’s Hospital,Jining 272000,Shandong Province,China)
Abstract:ObjectiveTo observe the clinical efficacy of HuaTanQuYu prescription combined with transcatheter arterial chemoembolization (TACE) treating advanced primary liver cancer patients.MethodsThe 68 patients with advanced hepatocellular carcinoma were divided into two groups according to a random number table,the control group of 33 patients (TACE treatment) and the treatment group of 35 patients (HuaTanQuyu prescription+TACE treatment).After 3 months of treatment,we observed the indices changes including liver function,KPS score,tumor markers,tumor size and TCM syndromes score.ResultsThe short-term curative response rate of treatment group and control group were 65.71% and 42.42% respectively,there was a statistically significant difference (P<0.05);after 28 days of treatment,the levels of liver function indices including alanine aminotransferase (ALT),aspartate aminotransferase (AST) and gamma-glutamyltranspeptidase (GGT) were decreased significantly in the treatment group,which were better than the control group (P<0.05);after 3 months of treatment,compared with the control group,the treatment group in improving the quality of life (KPS score) and TCM syndrome (fatigue,hypochondriac pain,abdominal distention,loose stools and anorexia) had advantages (P<0.05).ConclusionThe treatment of HuaTanQuYu prescription combined with TACE has a significant effect in advanced hepatocellular carcinoma.
Keywords:advanced hepatocellular carcinoma;transcatheter arterial chemoembolization;HuaTanQuYu prescription;salvia;pinellia
原发性肝癌(primary hepatic carcinoma,PHC)是我国最常见的恶性肿瘤之一,其起病隐匿,潜伏期长,恶性度高,生存期短,生存质量差,治疗颇为棘手。近年来,肝癌的发病率有逐渐上升的趋势,如何提高晚期肝癌患者的生存质量及延长生存期是目前临床的一大难题。在我国的肝癌防治研究中,中医药发挥了重要而又独特的作用,也开展了广泛的临床与机制研究[1-2],笔者采用化痰祛瘀法联合TACE治疗原发性肝癌,取得了较好的效果,现报道如下。
1临床资料
2012年6月—2013年12月,我院收治的68例原发性肝癌患者,男52例,女16例,年龄32~76岁,平均45.3岁。全部病例病灶直径2~11 cm,均做过B超……
